SmartTRAK has partnered with Alpha Sophia to launch a new medtech sales targeting solution. This innovative tool integrates Alpha Sophia’s advanced analytics with SmartTRAK’s comprehensive market insights to help companies identify key physicians and optimize their sales strategies. By combining actionable data with strategic market intelligence, the solution aims to accelerate product adoption and drive growth in the medtech sector. This collaboration marks a significant enhancement to SmartTRAK’s platform, providing users with more robust tools for market success. To read more, click here.
The Patient-Centered Outcomes Research Institute (PCORI) announced the approval of funding awards totaling more than $165 million for new patient-centered comparative clinical effectiveness research (CER), as well as research to improve methods and strengthen the science of engagement in patient-centered CER, according to a press release. There are two, multiphase CER studies. Researchers will compare two commonly prescribed beta blockers in patients with heart failure and implantable cardioverter defibrillators (ICDs). In the second study, researchers will compare different methods for monitoring pacemakers and ICDs that use wireless remote monitoring. To read more, click here.
MD Ally, which provides 911 diversion, care, and navigation solutions, announced the successful completion of a $14 million Series A funding round. Frist Cressey Ventures, founded by Senator Bill Frist and Bryan Cressey, led the round. It was anchored by General Catalyst, with participation from Techstars, Seae Ventures, Red & Blue Ventures, and Alumni Ventures, according to a press release. The new funding will enable MD Ally to open up access to its solution to other forward-thinking public safety and payor partners that have been waiting to achieve similar outcomes. To read more, click here.
Guardoc Health, an AI-powered SaaS platform designed by nurses for nurses to transform medical compliance and enhance patient care, raised $3M in seed funding, led by the Israeli venture firm Pitango HealthTech, according to a press release. Bertelsmann Investments, Springbank, Fresh.fund and Oded Barel-Sebag also participated in the round. To read more, click here.
Photo: champpixs, Getty Images
This is a paid member feature of MedCitizens. Please submit here and join!